Normal Values of Facial Thermography

This study has been completed.
Sponsor:
Collaborator:
Greer Laboratories
Information provided by:
West Penn Allegheny Health System
ClinicalTrials.gov Identifier:
NCT00411606
First received: December 12, 2006
Last updated: April 3, 2009
Last verified: April 2009
  Purpose

An objective of this study is to standardize temperature values derived from thermograms of the facial region. It is anticipated that the mean temperature of a defined region of interest, such as the eyes, nose, or sinuses, might be useful for future applications.

The investigators will attempt to determine normal temperature ranges based on participants' age and gender.


Condition Intervention
Healthy
Allergy
Allergic Rhinoconjunctivitis
Procedure: Thermography

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Normal Values of Facial Thermography

Resource links provided by NLM:


Further study details as provided by West Penn Allegheny Health System:

Estimated Enrollment: 300
Study Start Date: December 2006
Study Completion Date: July 2008
Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
Subjects with no allergies
Procedure: Thermography
Subjects will have a picture of their face taken with a thermal camera

Detailed Description:

Medical thermography is a noninvasive technique that allows an examiner to visualize and estimate the temperature of the skin surface. An infrared scanning device is used to convert infrared radiation emitted from the skin surface into electrical impulses that can be captured as an image called a thermogram. During the past 20 years medical thermography has been used to study the pathology in the vascular, muscular, neural and skeletal systems.

An objective of this study is to standardize temperature values derived from thermograms of the facial region. It is anticipated that the mean temperature of a defined region of interest, such as the eyes, nose, or sinuses, might be useful for future applications. This protocol addresses the definition of overall health, symptomology, and anthropometrical features (age, weight, height, body mass index and gender), and what effect, if any, each has on mean temperature. Environmental conditions, mapping procedures, and image evaluations will also be standardized. We will attempt to determine normal temperature ranges based on participants' age and gender. Future use of standardized values will be to assess the severity of rhinoconjunctivitis symptoms being experienced by a subject.

Subjects will make one visit to our clinic. They will be asked to acclimate to room temperature for at least 30 minutes. Subjects are requested not to consume hot drinks or food for at least an hour before imaging and not to use any skin preparations such as creams or talcum powder. A picture of the participant's face will be taken using the thermal camera which will demonstrate the temperature of each facial area of interest.

Please note that participants in this study will take part on a completely voluntary basis. No payment will be provided.

  Eligibility

Ages Eligible for Study:   7 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

outpatient subjects at Allegheny General Hospital

Criteria

Inclusion Criteria:

  • Between ages 7 and 70
  • No mobility problems
  • No restrictions in performing normal activities
  • No regular pain or discomfort
  • No anxiety or depression

Exclusion Criteria:

  • Restrictions in performing normal activities
  • Regular pain
  • Anxiety or Depression
  • Mobility problems
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00411606

Locations
United States, Pennsylvania
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States, 15212
Sponsors and Collaborators
West Penn Allegheny Health System
Greer Laboratories
Investigators
Principal Investigator: David Skoner, MD West Penn Allegheny Health System
  More Information

No publications provided

Responsible Party: David Skoner/Principal Investigator, Allegheny General Hospital
ClinicalTrials.gov Identifier: NCT00411606     History of Changes
Other Study ID Numbers: RC - 4220
Study First Received: December 12, 2006
Last Updated: April 3, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by West Penn Allegheny Health System:
Healthy
Allergy
Allergic Rhinoconjunctivitis

Additional relevant MeSH terms:
Hypersensitivity
Conjunctivitis, Allergic
Conjunctivitis
Immune System Diseases
Conjunctival Diseases
Eye Diseases
Hypersensitivity, Immediate

ClinicalTrials.gov processed this record on July 24, 2014